 | | | | Arrowhead Pharmaceuticals Inc on Monday entered a drug development deal with GlaxoSmithKline Plc under which the British drugmaker will develop and market Arrowhead's potential treatment for patients with fatty liver disease NASH. | | | | | | The U.S. Centers for Disease Control and Prevention (CDC) on Monday advised against travel to Germany and Denmark because of a rising number of COVID-19 cases in those countries. | | | | | | Germany's acting Chancellor Angela Merkel told leaders of her conservative party that measures being taken to stop the spread of the coronavirus in Europe's biggest economy were insufficient and that stronger action needed to be taken. | | | | | | The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. | | | | | | Austria became on Monday the first country in western Europe to reimpose lockdown since vaccines were rolled out, shutting non-essential shops, bars and cafes as surging caseloads raised the spectre of a second straight winter in deep freeze for the continent. | | | | | | The European Commission aims to harmonize the duration of the validity of the COVID-19 vaccination certificate, including the effects of booster shots, Health Commissioner Stella Kyriakides said on Monday, amid record infection numbers in some EU states. | | | | | | Health Minister Roberto Speranza on Monday said it will be possible for the Italians to receive a COVID-19 vaccine booster five months after completing the first vaccination cycle. | | | | | | Israel began rolling out Pfizer/BioNtech COVID-19 vaccinations for 5- to 11-year-olds on Monday hoping to beat down a recent rise in coronavirus infections. | | | | | | Theranos founder Elizabeth Holmes was back on the witness stand on Monday in her defense against fraud charges, telling jurors about the now-defunct blood-testing startup's technology and positive results from early studies. | | | | | | Chinese tech giant Baidu Inc said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker. | | | | | |
